Close menu




April 22nd, 2020 | 08:48 CEST

Lufthansa, Osino Resources, Wirecard - exciting opportunities for investors

  • Investments
Photo credits: pixabay.com

Social life has changed by 180 degrees since February 2020 with the spread of the Corona Virus Covid-19. Business people spend more time in video conferences than on planes, trains or cars. The time spent in the office is often minimized and work is done from home instead. Family time was also called 'quality time' before the pandemic, but when it becomes a duty it can also become a test of patience, especially when economic uncertainty increases around you. A rapid economic recovery is no longer an option. With each day of social and economic restrictions, the effects are also increasing. But the changes also produce winners.

time to read: 2 minutes | Author: Mario Hose
ISIN: CA68828L1004 , DE0008232125 , DE0007472060

Table of contents:


    Crisis currency gold

    Central banks and governments around the world have taken measures to mitigate the economic consequences of the Corona Pandemic. Popular options are intervention through rate cuts and increases in the money supply. The value of money decreases accordingly and inflation increases.

    Those who want to avoid this devaluation do not have much choice. Gold has historically established itself as a crisis currency, because nobody can print the precious metal. Against this background, the demand for physical gold in the form of bars and coins is growing. However, popular products are becoming increasingly rare, even with traders like Degussa.

    Gold investment for a limited time

    Anyone interested in the origins and value creation of gold should consider the shares of companies that focus on precious metals as an alternative. Of interest in this context is the Canadian company Osino Resources, which is managed by the experienced CEO Heye Daun. The company is focused on the discovery of gold deposits in its own areas in Namibia.

    Heye Daun is not new in the business and has already successfully built up a gold company in Namibia in the past and sold to the major player B2Gold. For investors it is important that the management knows how the market works. Osino Resources will continue to collect additional data from the areas with further drilling programs, thereby increasing its own attractiveness for potential buyers.

    Price potential up to USD 3,000.00

    Meanwhile Bank of America is now predicting that the price of the troy ounce of gold could rise to USD 3,000.00 in the next 18 months. In 2021 an average price of USD 2,063.00 is expected. An optimal scenario for the gold sector. If it does happen, this development fits perfectly with Osino Resources' strategy, because the bride will be pretty by then if successful.

    DAX companies in focus

    The airline Lufthansa is one of the world's most famous travel companions. However, the current restrictions have ensured that Lufthansa's load factor is now only 5%. The flight schedule has been reduced accordingly. However, the time after the pandemic will not mean that the usual load factor will be restored overnight. Old habits will give way to new habits. Investors need patience.

    KPMG's special report on Wirecard is eagerly awaited today. This follows accusations by the Financial Times about dubious contracts and partners. The payment service provider can navigate its way through the Corona Crisis relatively unscathed due to online business.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read